Australia markets closed

Scopus BioPharma Inc. (SCPS)

OTC Markets EXMKT - OTC Markets EXMKT Delayed price. Currency in USD
Add to watchlist
0.00020.0000 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-8,696
-11,610
-26,953
-10,862
-2,690
Depreciation & amortisation
1.102
1.728
1.5
1.44
0.664
Stock-based compensation
317.881
351.721
669.602
290.407
213.649
Change in working capital
5,981
3,235
2,841
1,149
355.234
Other working capital
-3,043
-8,128
-11,427
-2,525
-2,125
Other non-cash items
-
-
13,472
6,896
-
Net cash provided by operating activities
-3,043
-8,127
-11,425
-2,525
-2,120
Cash flows from investing activities
Investments in property, plant and equipment
-
-1.552
-1.999
-
-4.251
Net cash used for investing activities
0
-1.552
-1.999
0
-4.251
Cash flows from financing activities
Debt repayment
-
0
-104.505
0
-
Common stock issued
1,975
0
20,100
3,274
1,777
Other financing activities
-
241.942
-2,439
-1,110
-451.642
Net cash used provided by (used for) financing activities
2,217
241.942
17,557
4,353
2,184
Net change in cash
-794.368
-7,818
6,111
1,795
35.087
Cash at beginning of period
1,156
7,943
1,832
36.747
1.66
Cash at end of period
330.521
124.575
7,943
1,832
36.747
Free cash flow
Operating cash flow
-3,043
-8,127
-11,425
-2,525
-2,120
Capital expenditure
-
-1.552
-1.999
-
-4.251
Free cash flow
-3,043
-8,128
-11,427
-2,525
-2,125